1. Unique Clindamycin-Resistant Clostridioides difficile Strain Related to Fluoroquinolone-Resistant Epidemic BI/RT027 Strain.
- Author
-
Skinner AM, Petrella L, Siddiqui F, Sambol SP, Gulvik CA, Gerding DN, Donskey CJ, and Johnson S
- Subjects
- Aged, Aged, 80 and over, Anti-Bacterial Agents pharmacology, Clindamycin pharmacology, Clostridioides difficile drug effects, Clostridioides difficile genetics, Drug Resistance, Bacterial, Enterocolitis, Pseudomembranous drug therapy, Enterocolitis, Pseudomembranous microbiology, Feces microbiology, Female, Humans, Illinois epidemiology, Male, Ohio epidemiology, Polymerase Chain Reaction, Prohibitins, Whole Genome Sequencing, Clostridioides difficile isolation & purification, Enterocolitis, Pseudomembranous epidemiology, Long-Term Care
- Abstract
During a surveillance study of patients in a long-term care facility and the affiliated acute care hospital in the United States, we identified a Clostridioides difficile strain related to the epidemic PCR ribotype (RT) 027 strain associated with hospital outbreaks of severe disease. Fifteen patients were infected with this strain, characterized as restriction endonuclease analysis group DQ and RT591. Like RT027, DQ/RT591 contained genes for toxin B and binary toxin CDT and a tcdC gene of identical sequence. Whole-genome sequencing and multilocus sequence typing showed that DQ/RT591 is a member of the same multilocus sequence typing clade 2 as RT027 but in a separate cluster. DQ/RT591 produced a similar cytopathic effect as RT027 but showed delayed toxin production in vitro. DQ/RT591 was susceptible to moxifloxacin but highly resistant to clindamycin. Continued surveillance is warranted for this clindamycin-resistant strain that is related to the fluoroquinolone-resistant epidemic RT027 strain.
- Published
- 2020
- Full Text
- View/download PDF